An open-label multicenter phase II study of oral lapatinib (GW572016) as single agent, second-line therapy in patients with metastatic colorectal cancerAnthony Fields, M. S. Berger, L. Leopold et al.|Journal of Clinical Oncology|2005Cited by 48
Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphomaJonathan C. Yau, Glenwood Goss, Terry Koski et al.|American Journal of Hematology|1998Cited by 6
Phase I-II Study of 5-Fluorouracil, Leucovorin, Doxorubicin, Methotrexate, and Long-Term Oral Etoposide (FLAME) in Unresectable or Metastatic Gastric CancerGeorg A. Bjarnason, Hélène Dulude, C. Cripps et al.|American Journal of Clinical Oncology|1998Cited by 2